Floris Engelhardt

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts.

The Engine Accelerator, Inc. (The Engine) is a venture capital firm founded in 2016. The firm is headquartered in Cambridge, Massachusetts.

Cambridge Crops, Inc. provides edible and natural biomaterial coating services. It uses salt and water to extract the protein from silk to create an edible protective layer that keeps food fresh for longer. The company was founded by Fiorenzo Omenetto, Livio Valenti, Jacques-Henry Grislain and Benedetto Marelli and is headquartered in Boston, MA.

Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA.

Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA.

Quaise Energy, Inc. engages in the development and commercialization of novel millimeter wave drilling systems to harness geothermal energy. Its technology enables the clean energy transition by accessing the largest source of power-dense clean energy. The company was founded in 2018 and is headquartered in Cambridge, MA.

Lucy Therapeutics, Inc. operates as a biotech firm. It offers a novel approach to drug discovery by drugging targets associated with early disease pathogenesis. The company was founded by Amy Ripka and is headquartered in Cambridge, MA.